Globus Medical, Inc. (GMED) Earnings History
Elite Compounder16 years of earnings data (2010–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
Globus Medical, Inc. (GMED) Earnings Overview
As of June 23, 2026, Globus Medical, Inc. (GMED) reported trailing twelve-month net income of $587M, reflecting +422.7% year-over-year growth. The company earned $4.25 per diluted share over the past four quarters, with a net profit margin of 18.3%.
Looking at the long-term picture, GMED's 5-year EPS compound annual growth rate (CAGR) stands at +31.2%, indicating exceptional earnings growth. The company achieved its highest annual net income of $538M in fiscal 2025, representing a new all-time high.
Globus Medical, Inc. maintains industry-leading profitability with a gross margin of 67.4%, operating margin of 16.3%, and net margin of 18.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including SYK ($3.25B net income, 12.9% margin), ZBH ($761M net income, 8.6% margin), ATEC (-$125M net income, -18.8% margin), GMED has outperformed on profitability metrics. Compare GMED vs SYK →
GMED Earnings vs Peers
Earnings metrics vs comparable public companies
GMED Historical Earnings Data (2010–2025)
16 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $538M | +422.3% | $480M | $3.92 | 18.3% | 16.3% |
| 2024 | $103M | -16.2% | $166M | $0.75 | 4.1% | 6.6% |
| 2023 | $123M | -35.4% | $133M | $1.07 | 7.8% | 8.5% |
| 2022 | $190M | +27.5% | $228M | $1.85 | 18.6% | 22.3% |
| 2021 | $149M | +45.9% | $172M | $1.44 | 15.6% | 17.9% |
| 2020 | $102M | -34.1% | $111M | $1.01 | 13.0% | 14.1% |
| 2019 | $155M | -0.8% | $172M | $1.52 | 19.8% | 21.9% |
| 2018 | $156M | +45.8% | $169M | $1.54 | 21.9% | 23.7% |
| 2017 | $107M | +2.9% | $162M | $1.10 | 16.9% | 25.4% |
| 2016 | $104M | -7.5% | $154M | $1.08 | 18.5% | 27.3% |
| 2015 | $113M | +21.9% | $172M | $1.17 | 20.7% | 31.6% |
| 2014 | $92M | +34.8% | $138M | $0.97 | 19.5% | 29.2% |
| 2013 | $69M | -7.1% | $102M | $0.73 | 15.8% | 23.4% |
| 2012 | $74M | +21.5% | $115M | $0.80 | 19.1% | 29.7% |
| 2011 | $61M | +11.6% | $97M | $0.81 | 18.3% | 29.4% |
| 2010 | $54M | - | $88M | $0.72 | 18.9% | 30.4% |
Download Data
Export GMED earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into GMED consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
16+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GMED — Frequently Asked Questions
Quick answers to the most common questions about buying GMED stock.
What is GMED earnings per share (EPS)?
GMED trailing twelve-month (TTM) diluted EPS is $4.25, reflecting +422.7% year-over-year growth. The 5-year EPS CAGR is +31.2%. Complete EPS history from 2010 to 2025 is available in the table on this page.
What is Globus Medical, Inc.'s net income?
Globus Medical, Inc. (GMED) trailing twelve-month net income is $587M as of 2025. Earnings grew +422.7% year-over-year. Globus Medical, Inc. has been profitable for 16 consecutive years.
Is GMED profitable?
Yes, GMED is profitable with a TTM net income of $587M and a net profit margin of +18.3%. Globus Medical, Inc. has generated profits for 16 consecutive years.
What is GMED's earnings growth rate?
GMED compound annual EPS growth rates (CAGR): 1-Year: +422.7%, 3-Year: +28.4%, 5-Year: +31.2%, 10-Year: +12.9%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2010 to 2025.
What are GMED's profit margins?
Globus Medical, Inc. net profit margin is +18.3%, operating margin is +16.3%, and gross margin is +67.4%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +12.3%.
Is GMED growing earnings?
Yes, GMED earnings are accelerating — EPS growth of +422.7% exceeds the 5-year CAGR of +31.2%. TTM net income reached $587M. Earnings momentum is strengthening.
What was GMED's best earnings year?
Globus Medical, Inc.'s highest annual net income on record is $538M, achieved in fiscal year 2025. Earnings history on this page spans 2010 to 2025 and includes all annual and quarterly figures.
What were GMED's earnings last quarter?
GMED's most recent reported quarter was Q1 2026. Net income was $124M with diluted EPS of $0.90. For a full breakdown of all quarters, see the quarterly earnings table on this page.